Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation

Gastrointestinal inflammation is a hallmark of highly prevalent disorders, including cancer treatment–induced mucositis and ulcerative colitis. These disorders cause debilitating symptoms, have a significant impact on quality of life, and are poorly managed. The activation of toll-like receptor 4 (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Tam, Janine S. Y., Coller, Janet K., Hughes, Patrick A., Prestidge, Clive A., Bowen, Joanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934812/
https://www.ncbi.nlm.nih.gov/pubmed/33666891
http://dx.doi.org/10.1007/s12664-020-01114-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934812/
https://www.ncbi.nlm.nih.gov/pubmed/33666891
http://dx.doi.org/10.1007/s12664-020-01114-y

Ejemplares similares